e-learning
resources
Monograph
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Animal models of VAP
D. Bruno, J. García-Morato, C.M. Luna
Source:
Eur Respir Monogr 2011; 53: 98-112
Journal Issue:
Nosocomial and Ventilator-Associated Pneumonia
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Bruno, J. García-Morato, C.M. Luna. Animal models of VAP. Eur Respir Monogr 2011; 53: 98-112
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Animal models of ventilator-associated pneumonia
Source: Eur Respir J 2009; 33: 182-188
Year: 2009
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
Source: Eur Respir J 2010; 35: 598-615
Year: 2010
What lessons have been learnt from animal models of MRSA in the lung?
Source: Eur Respir J 2010; 35: 198-201
Year: 2010
Aetiopathogenesis of VAP revisited
Source: Eur Respir Mon 2011; 53: 1-10
Year: 2011
Experimental Pseudomonas aeruginosa pneumonia: evaluation of the associated inflammatory response
Source: Eur Respir J 2007; 30: 1167-1172
Year: 2007
What is MRSA?
Source: Eur Respir J 2009; 34: 1190-1196
Year: 2009
Broad spectrum of virulence of
pseudomonas aeruginosa
clones characterized in a murine airway infection model
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Early mortality in patients with community-acquired pneumonia: causes and risk factors
Source: Eur Respir J 2008; 32: 733-739
Year: 2008
MRSA as a cause of lung infection including airway infection, community-acquired pneumonia and hospital-acquired pneumonia
Source: Eur Respir J 2009; 34: 1470-1476
Year: 2009
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia
Source: Eur Respir J 2007; 29: 548-560
Year: 2007
An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets
Source: Eur Respir J 2010; 36: 901-906
Year: 2010
Diagnostic challenge in community-acquired pneumonia and hospital-acquired pneumonia: risk factors and diagnostic methods for methicillin resistant
Staphylococcus aureus
Source: Annual Congress 2006 - Methicillin resistant
Staphylococcus aureus
(MRSA): a real hospital-based pathogen?
Year: 2006
Community-acquired pneumonia in Europe: causative pathogens and resistance patterns
Source: Eur Respir J 2002; 20: 20S-27S
Year: 2002
Community-acquired pneumonia due to S. aureus
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Incidence, characteristics and outcomes of patients with severe community acquired-MRSA pneumonia
Source: Eur Respir J 2009; 34: 1148-1158
Year: 2009
Human airway epithelial cell response to
Pseudomonas aeruginosa
virulence factors preceded or not by
Staphylococcus aureus
Source: Eur Respir J 2006; 28: Suppl. 50, 191s
Year: 2006
The role of the type 3 secretion system effector protein ExoY during pathogenesis of
pseudomonas aeruginosa
lung infections
Source: International Congress 2014 – Pathogenesis and mechanisms of respiratory infections
Year: 2014
Streptococcus pneumoniae
resistance pattern and its clinical implications
Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections
Year: 2006
Mesenchymal stem cells enhance bacterial clearance of streptococcal pneumoniae and pseudomonas aeruginosa in the lung
Source: International Congress 2016 – Microbiological issues and translational research in respiratory infections
Year: 2016
Peculiarities of community-acquired pneumonia course, caused by multiresistant strains of
S. pneumoniae
Source: Eur Respir J 2006; 28: Suppl. 50, 165s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept